Seoul, National

Seoul National University Bundang Hospital Establishes the first International PSP Research and Treatment Center in Korea

07.08.2025 - 18:03:44 | prnewswire.co.uk

GemVax & KAEL New York South Korea Quebec

MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment CenterTackling Global Challenges in an Aging Era… "Aspiring to become a global research and treatment hub for the rare neurodegenerative disease"and follow us on Linkedin

Forward-Looking Statements

This document contains information that includes or is based upon "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements may or may not include identifying words such as "plan," "will," "expect," "anticipate," "intend," "believe," "potential," "continue," and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties. All forward-looking statements are based on management's current estimates, projections, and assumptions, and GemVax undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.

GemVax Logo

Photo - https://mma.prnewswire.com/media/2576147/Representatives_took_a_photo_after_signing_an_MOU_for_the_establishment_of_the_lnternational_PSP_Res.jpg
Logo - https://mma.prnewswire.com/media/2542900/GemVax_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/seoul-national-university-bundang-hospital-establishes-the-first-international-psp-research-and-treatment-center-in-korea-302326024.html

So schätzen die Börsenprofis Seoul Aktien ein!

<b>So schätzen die Börsenprofis  Seoul Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | CA7609751028 | SEOUL | boerse | 67994009 |